Loading menu…

Role of Short Term Tamsulosin in Medical Management of Lower Ureteric Calculi in Today’s Modern Era of Increasing Demand of Various Advancing Endo-Urological Procedures

Send Message

To: Author

Role of Short Term Tamsulosin in Medical Management of Lower Ureteric Calculi in Today’s Modern Era of Increasing Demand of Various Advancing Endo-Urological Procedures

Article Fingerprint

ReserarchID

PDDTM59KZ7

Role of Short Term Tamsulosin in Medical Management of Lower Ureteric Calculi in Today’s Modern Era of Increasing Demand of Various Advancing Endo-Urological Procedures Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background

I. INTRODUCTION

The choice of ideal method like MET or URS to treat lower ureteric calculi depends on the type of equipment available, type and size of stone, needs of the patient and skills of the surgeon [1]. The stone burden remains the primary factor in deciding the appropriate treatment for a patient with ureteric calculi [2].

Expectantly managed patients who develop recurrent pain, sepsis, or compromised renal function need drainage if necessary followed by stone clearance using endoscopy or extracorporeal shock wave lithotripsy [3].

The smooth muscle relaxant drug tamsulosin (an α -adrenoceptor antagonist) is a possible agent, its use being termed medical expulsive therapy (MET)[4]. Meta-analyses of data from randomised controlled trials (RCTs) report a statistically significant benefit fortamsulosin over controls for the outcome of spontaneous stone passage [5,6].

Where a failed expectant treatment may well be complicated with hydro-nephrosis, deranged renal function or urosepsis. Interventional techniques are not always free of complications and failures. Most of the work of the efficacy of tamsulosin in lower ureteric calculi expulsion has been done in western affluent countries with variable results. The disease spectrum in a developing country like ours is different from that of developed countries, mainly because of delay in diagnosis, delay in investigations and lack of awareness that tend to modify outcome in case of ureteral stones or for that matter any disease. More so, advanced interventional facilities in this part of the world are not easily available. A prospective study was thus planned to compare the tamsulosin group with a control group in our setup to evaluate the efficacy of tamsulosin for lower ureteric calculi expulsion within a few days without the need for hospitalisation, common endoscopic treatment or shock wave lithotripsy.

II. METHODOLOGY

After taking clearance/permission from the ethical committee of our hospital we did a Prospective randomised control study from feb 2014 to feb 2017 including 600 subjects in age group of 20-50 years with unilateral ureteric calculi of size 4mm-10mm. Patients having acute renal failure, chronic renal failure, urinary tract infection, fever & who have recently undergone surgery for ureteric calculi were not included in the study. The study group was given cap Tamsulosin 0.4mg& tablet Dytor 10mg once daily for a maximum of 2 weeks or till the stone was passed (whichever was earlier). Analgesic (table tdiclofenac 100mg) was given as needed. The control group was given analgesic and diuretic tablets only for same period. During the study time a ultra sonography (KUB)was done on day 0 of starting tamsulosin treatment followed by on day 7, day 14 and day 17. Results were compared between the study group and the control group in terms of stone passage rate, time taken to pass the stone, pain score during the treatment period, number & frequency of colic episodes and need for surgical intervention. Data was entered into MS word & Microsoft excel data sheet. Data was analysed using MS Excel, SPSS version 22 (IBM SPSS Statistics, Somers NY, USA). SPSS 22 version software. Categorical data was represented in the form of frequencies and proportions. Chi-Square test was used as test of significance. Continuous data was represented as mean and standard deviation. Independent t test (student's t test) was used as test of significance to identify the mean difference between two groups.p value < 0.05 was considered as statistically significant. Patients were randomized by using computer generated randomization from web site Randomization.com http://www.randomization.com. Double blinding was followed during the study period.

III. RESULTS & OBSERVATIONS

All patients in our study were between the age group of 20-50 years. In our study the incidence of ureteric calculi was found to be more in males (81.44%) as compared to females (18.54%). We found incidentally that more stones were on the right side (51.61%) as compared to the left side (48.38%). No patient in group 1 had pain score in the range of 8-10 whereas 3.22% of patients in group 2 had a pain score in the range of 8-10. 83.87% of stones in group 1 & 62.90% stones in group 2 passed out successfully. 17.74% of patients in group 1 & 37.09% of patients in group 2 needed surgical intervention. However the need for surgical intervention for stone size up to 6mm was same in both the groups.

Table 1: Demographics of the study
Mean ageMalefemaleLeft side stonesRight side stonesMean stone size (USG)
GroupTamsulosin35.6 ± 8.5230(74.2%)80(25.8%)1651457.5 ± 1.5 mm
WW35.9 ± 8.1275(88.7%)35(11.3%)1351757.7 ± 1.4mm
p value0.697<0.0010.0160.132
Table 2: Outcomes in the two groups
Passed calculi in <14 days (%)Not passed calculiMean no. of colic episodesMean pain scoreNeed for hospitalisation during treatmentNeed for surgical intervention
groupsTamsulosin260 (83.87%)50 (16.12%)3 ± 1.74.1 ± 1.77555 (17.74%)
WW195 (62.9%)115 (37.09%)4.2 ± 2.25.1 ± 1.8135115 (37.09%)
p value<0.001<0.001< 0.001< 0.001<0.001<0.001

Figure: Pie diagram showing Surgical intervention comparison between two groups

IV. DISCUSSION

Treatment modalities for ureteral stones have greatly changed during the last 20 years, especially following the introduction of minimally invasive procedures such as extra-corporeal shock wave lithotripsy and uretero-renoscopy. The advantage of the medical expulsive therapy is important, because the risks which are related to a surgical intervention are not trivial [7]. Studies have reported the overall complication rates after ureteroscopic lithotripsies to be 10–20%, with major complications such as ureteral perforations, avulsions and strictures occurring during 3–5% of the procedures [7]. Urinomas and sub capsular bleeds have been reported in 15–32% of the patients who are treated with shock wave lithotripsy [8]. Hollingsworth et al reported a 1.1% overall prevalence of MET use between 2000 and 2006 in emergency departments in the USA, with a missed opportunity of sparing approximately 260,000 individuals annually from stone surgery[9]. 70% of urolithiasisare located in the lower third of the ureter. Determining factors for spontaneous passage of stones are their size, their configuration, and the smooth muscle activity of the ureters. In the transport of stones, the greatest obstacle is usually the terminal part of the ureters, mainly in the intramural 'detrusor tunnel. Antagonists of the alpha-1-adrenergic receptor, in particular, inhibit basal tone and decrease peristaltic frequency and amplitude with the consequences of increased fluid transport and decreased intra-ureteral pressure; they also block the conduction of visceral referred pain to the central nervous system, acting on C-fibres or sympathetic postganglionic neurons [10,11,12,13]. Both the European (EAU) and American Urological Associations (AUA) outline the role of alpha-blockers as a viable option in a select patient population who are comfortable with the approach and where there is no role for immediate surgical stone removal [14,15]. The role of alpha-blockersin MET has been well described[14-15]. The role of adrenergic receptors in the human ureter was first described in 1970 [16]. It was shown later, that the alpha-adrenergic receptors were classified into three different subtypes &the distribution in the human ureter was α1D>α1A>α1B [17]. It was also shown that the alpha-adrenergic receptor agonists had a stimulatory effect on the ureteral smooth muscle, whereas the beta-adrenergic receptor agonists had an inhibitory effect [18]. They prevent the uncoordinated muscle activity which is seen in renal colic, while maintaining ureteral peristalsis, which might facilitate a spontaneous stone passage [19]. The treatment effect on the expulsion rate was partially lost, as the sizes of the stones decreased, because of the high spontaneous expulsion rate of the small stones [2,20]. Our study included only solitary ureteral calculi & located in the distal one third of the ureter. Current best practice guidelines recommend alpha-blockers for the expulsion of distal ureteral stones. Meta-analyses have demonstrated that patients treated with alpha-blockers are more likely to pass stones with fewer episodes of colic [8,21]. Two recent randomized controlled studies by Al-Ansari et al [22] and Kaneko et al [23] validated the efficacy of tamsulosin for distal ureteral calculi. However, a randomized control trial by Yilmaz et al demonstrated that tamsulosin, terazosin, and doxazosin were equally effective in distal stone expulsion in comparison to the control group [24]. There is no role of tamsulosin orwatchfulwaitingninstonesofrsizen≥n10mmr & Surgical intervention is the treatment of choice. In a recent study by Prof Robert Pickard et al [25] where they gave tamsulosin for 4 weeks they found that spontaneous stone passage, did not differ between groups. Comparing it with other studies we used tamsulosin maximum only for 2 weeks. In our study it was found that the use of tamsulosin increased the stone expulsion rate (83.87% in tamsulosin group compared to 62.9% in control group). We also found that the use of tamsulosin reduced pain and need for surgical intervention (17.74% in tamsulosin group compared to 37.09% in control group).

V. CONCLUSION

In our study incidence of ureteric calculi was found to be more in males in the age group of 31-40 years& on the right side.Use of tamsulosin in MET for lower ureteric calculi upto 9mm helps in expulsion of stone, reduces the need for hospital admission, reduces pain, reduces the need for oral analgesics and reduces the need for surgical intervention. There was no significant difference in number of days required for expulsion of stones between two groups. There was no significant difference in mean size of stone passed in two groups. The possibility of expulsion of ureteric calculi spontaneously or with tamsulosin reduces as the stone size increases (maximum possibility with 5mm and minimum possibility with 9mm). There is no role of tamsulosin/watchful waiting in ureteric calculusofrsizen≥n 10mm. Most common Complications associated with tamsulosin are giddiness, retrograde ejaculation. Tamsulosin therapy is not cost effective than watchful waiting but cost effective than surgical intervention. However our study had only two groups, one study group and one control group. Adding two more groups simultaneously, one with some other alpha blocker drug and one with no drugs given at all, may show us the exact efficacy of tamsulosin

References

25 Cites in Article
  1. 1. Thijs Campschroer,Yefang Zhu,Diederick Duijvesz,Diederick Grobbee,Mtwt Lock (2014). Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database of Systematic Reviews, 4, 8509.
  2. 2. Christian Seitz,Evangelos Liatsikos,Francesco Porpiglia,Hans-Göran Tiselius,Ulrike Zwergel (2009). Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence?. European Urology, 56(3), 455-471.
  3. 3. Khurshid Ghani,Florian Roghmann,Jesse Sammon,Vincent Trudeau,Shyam Sukumar,Haider Rahbar,Ramesh Kumar,Pierre Karakiewicz,James Peabody,Mani Menon,Maxine Sun,Quoc-Dien Trinh (2014). Emergency Department Visits in the United States for Upper Urinary Tract Stones: Trends in Hospitalization and Charges. Journal of Urology, 191(1), 90-96.
  4. 4. (2012). NHS reference costs. NHS reference costs
  5. 5. R,M Eisner,B Porpiglia,F Preminger,G Tiselius,H-G (2012). Contemporary management of ureteral stones. Eur Urol, 61, 764V.
  6. 6. John Hollingsworth,Mary Rogers,Samuel Kaufman,Timothy Bradford,Sanjay Saint,John Wei,Brent Hollenbeck (2006). Medical therapy to facilitate urinary stone passage: a meta-analysis. The Lancet, 368(9542), 1171-1179.
  7. 7. G Daniels,J Garnett,M Carter (1988). Ureteroscopic results and complications: experience with 130 cases. J. Urol, 139, 710-713.
  8. 8. Yair Lotan,Matthew Gettman,Claus Roehrborn,Jeffrey Cadeddu,Margaret Pearle (2002). Management Of Ureteral Calculi: A Cost Comparison And Decision Making Analysis. Journal of Urology, 167(4), 1621-1629.
  9. 9. J Hollingsworth,M Davis,B West,J Wolf,Jr,B Hollenbeck (2009). Trends in medical expulsive therapy use for urinary stone disease in U.S. emergency departments. Urology, 74, 1206-1209.
  10. 10. Marco Dellabella,Giulio Milanese,Giovanni Muzzonigro (2005). Medical-expulsive therapy for distal ureterolithiasis: Randomized prospective study on role of corticosteroids used in combination with tamsulosin—simplified treatment regimen and health-related quality of life. Urology, 66(4), 712-715.
  11. 11. T Morita,I Wada,H Saeki,S Tsuchida,R Weiss (1987). Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. J Urol, 137, 132-135.
  12. 12. Manabu Ishigooka,Teruhiro Nakada,Tohru Hashimoto,Yoshiaki Iijima,Hiromasa Yaguchi (2002). Spinal substance P immunoreactivity is enhanced by acute chemical stimulation of the rat prostate. Urology, 59(1), 139-144.
  13. 13. Erik Kinnman,Eva-Britt Nygårds,Per Hansson (1997). Peripheral α -adrenoreceptors are involved in the development of capsaicin induced ongoing and stimulus evoked pain in humans. Pain, 69(1), 79-85.
  14. 14. C Turk,T Knoll,A Petrik (2014). Guidelines on urolithiasis. European Association of Urology
  15. 15. Glenn Preminger,Hans-Göran Tiselius,Dean Assimos,Peter Alken,A Colin Buck,Michele Gallucci,Thomas Knoll,James Lingeman,Stephen Nakada,Margaret Pearle,Kemal Sarica,Christian Türk,J Wolf (2007). 2007 Guideline for the Management of Ureteral Calculi. European Urology, 52(6), 1610-1631.
  16. 16. Joseph Malin,R Deane,S Boyarsky (1970). CHARACTERISATION OF ADRENERGIC RECEPTORS IN HUMAN URETER1. British Journal of Urology, 42(2), 171-174.
  17. 17. Yasunori Itoh,Yoshiyuki Kojima,Takahiro Yasui,Keiichi Tozawa,Shoichi Sasaki,Kenjiro Kohri (2007). Examination of alpha 1 adrenoceptor subtypes in the human ureter. International Journal of Urology, 14(8), 749-753.
  18. 18. R Weiss,A Bassett,B Hoffman (1978). Dynamic length-tension curves of cat ureter. American Journal of Physiology-Legacy Content, 222(2), 388-393.
  19. 19. V Tzortzis,C Mamoulakis,J Rioja,S Gravas,M Michel,J De La Rosette (2009). Medical expulsive therapy for distal ureteral stones. Drugs, 69, 677-692.
  20. 20. A Ueno,T Kawamura,A Ogawa,H Takayasu (1977). Relation of spontaneous passage of ureteral calculi to size. Urology, 10, 544.
  21. 21. Riccardo Autorino,Marco De Sio,Rocco Damiano,Giuseppe Di Lorenzo,Sisto Perdonà,Aniello Russo,Giuseppe Quarto,Luca Cosentino,Massimo D’armiento (2005). The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?. Urological Research, 33(6), 460-464.
  22. 22. Abdulla Al-Ansari,Abdulla Al-Naimi,Abdulkader Alobaidy,Khalid Assadiq,Mohamed Azmi,Ahmed Shokeir (2010). Efficacy of Tamsulosin in the Management of Lower Ureteral Stones: A Randomized Double-blind Placebo-controlled Study of 100 Patients. Urology, 75(1), 4-7.
  23. 23. Tomoyuki Kaneko,Hisashi Matsushima,Hirohiko Morimoto,Yasuo Tsuzaka,Yukio Homma (2010). Efficacy of low dose tamsulosin in medical expulsive therapy for ureteral stones in Japanese male patients: A randomized controlled study. International Journal of Urology, 17(5), 462-465.
  24. 24. Erdal Yilmaz,Ertan Batislam,Mehmed Basar,Devrim Tuglu,Mehmet Ferhat,Halil Basar (2005). THE COMPARISON AND EFFICACY OF 3 DIFFERENT α1-ADRENERGIC BLOCKERS FOR DISTAL URETERAL STONES. Journal of Urology, 173(6), 2010-2012.
  25. 25. Robert Prof,Kathryn Pickard,Graeme Starr,Thomas Maclennan,Ruth Lam,Jennifer Thomas,Gladys Burr,Alison Mc Pherson,Kenneth Mcdonald,Prof Anson,N' James,Neil Dow,Terry Burgess,Mary Clark,Katie Kilonzo,Kirsty Gillies,Charles Shearer,Sarah Boachie,Prof Cameron,John Norrie,Prof Msc,M Samuel Mcclinton (2015). Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet, 386, 41-49.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Aditya Avinash Yelikar. 2020. "Role of Short Term Tamsulosin in Medical Management of Lower Ureteric Calculi in Today’s Modern Era of Increasing Demand of Various Advancing Endo-Urological Procedures". Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 20 (GJMR Volume 20 Issue B2).

More Citation Formats

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-B Classification NLMC Code: WJ 140
Version of record
v1.2

Issue date
February 29, 2020

Language
English
Order Article Reprint
Experience in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 831
Total Downloads: 45
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Role of Short Term Tamsulosin in Medical Management of Lower Ureteric Calculi in Today’s Modern Era of Increasing Demand of Various Advancing Endo-Urological Procedures

Aditya Yelikar
Aditya Yelikar